ANGIOGENESIS INHIBITOR

Details for Australian Patent Application No. 2002349621 (hide)

Owner SANTEN PHARMACEUTICAL CO., LTD.

Inventors MATSUOKA, Hidehito; NISHIMURA, Kazuo; SEIKE, Hisayuki; AONO, Hiroyuki; MURAI, Masaaki

Pub. Number AU-A-2002349621

PCT Number PCT/JP02/12481

PCT Pub. Number WO2003/045367

Priority 2001-366088 30.11.01 JP

Filing date 29 November 2002

Wipo publication date 10 June 2003

International Classifications

A61K 031/17 - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

C07D 213/68 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/74 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/79 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/81 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/84 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/89 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/12 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 233/61 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07C 275/24 Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07C 311/46 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07F 007/18 Compounds containing elements of the 4th Group of the Periodic System

A61K 031/417

A61K 031/4402 - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 031/4406 - only substituted in position 3, e.g. zimeldine

A61K 031/4409 - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 031/4418 - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 031/4425 - Pyridinium derivatives, e.g. pralidoxime, pyridostigmine

A61K 031/443

A61K 031/4439

A61K 031/444

A61K 031/4545

A61K 031/47 - Quinolines

A61K 031/4725

A61K 031/506 - not condensed and containing further heterocyclic rings

A61K 031/5377

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 027/02 Drugs for disorders of the senses

A61P 027/06 Drugs for disorders of the senses

A61P 035/00 Antineoplastic agents

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07D 213/30 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/32 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/36 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 2001-366088 30.11.01 JP

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002349621

19 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002349622-SOFTWARE TIME-LENDING SYSTEM AND METHOD

2002349620-MULTIPLE RECORDING MEDIUM AND STORAGE DEVICE